3 completed. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow NeuTec Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivermectin for Severe COVID-19 Management Ivermectin - COVID-19 | Phase 3 | Completed | Afyonkarahisar Health Sciences University | 66 | 2020-05-11 | 2021-01-27 |
| Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer Mycograb, Docetaxel - Cancer of the Breast | Phase 1 / Phase 2 | Completed | NeuTec Pharma | 20 | 2005-09-01 | 2008-07-15 |
| Aurograb and Vancomycin in MRSA Infection Aurograb - Staphylococcal Infections | Phase 3 | Completed | NeuTec Pharma | 180 | 2004-01-01 | 2006-09-19 |
Breast Neoplasms (1) · COVID-19 (1) · Staphylococcal Infections (1)
Azithromycin (1) · Docetaxel (1) · Hydroxychloroquine (1) · Ivermectin (1) · efungumab (1) · favipiravir (1)
Poland (1) · Serbia (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Anna Pluzanska, MD (1) · Mark H Wilcox, MD (1)